Molecular Testing Overview: Current Trends
Molecular diagnostics has advanced in precision, accuracy, speed, and detection. There is much to commend, and much is to be done promising exciting health care solutions.
Read MorePosted by Clinical Lab Products | Sep 1, 2011 | Molecular Diagnostics |
Molecular diagnostics has advanced in precision, accuracy, speed, and detection. There is much to commend, and much is to be done promising exciting health care solutions.
Read MorePosted by Clinical Lab Products | May 27, 2011 | Cancer, Miscellaneous |
A company spokeswoman attributes the shortage to the company’s inability to meet increasing demand and the transition to a new plant for bottling and labeling operations.
Read MorePosted by Clinical Lab Products | May 1, 2011 | Cancer, Miscellaneous |
BioCare Medical LLC offers a new look at prostate cancer diagnosis.
Read MorePosted by Clinical Lab Products | Apr 6, 2011 | Cancer |
Amgen Cancer Drug Fails in Phase 3 Study Thousand Oaks, Calif — Amgen, Cambridge, Mass-based Millennium: The Takeda Oncology Company, and Takeda Pharmaceutical Co, Osaka, Japan, announced the top-line results from the pivotal
Read MorePosted by Clinical Lab Products | Mar 13, 2011 | Miscellaneous |
Sunesis Pharmaceuticals’ vosaroxin would be used in combination with cytarabine to treat acute myeloid leukemia.
Read More